SOLSTICE ADVANCED MATERIALS INC.

SOLS

CIK 0002064953 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$987M
↑+8.1% +$74Mvs FY2024 (Q4)
Operating Income
$62M
↓-56.6% -$81Mvs FY2024 (Q4)
Net Income
$7M
↓-94.7% -$126Mvs FY2024 (Q4)
Gross Profit
$258M
↓-15.4% -$47Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
19/100
  • Profitability
    0Insufficient data
  • Liquidity
    45Current Ratio 1.39 (above 1.5 = solid)
  • Leverage
    29D/E 1.42 (under 0.5 = conservative)
  • Efficiency
    41Asset Turnover 0.73x (1.0+ = capital-efficient)
  • Growth
    0Insufficient data
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project SOLS's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$12.88
Total enterprise IV
$2.05B
Diluted shares
0.16B
Terminal PV
$1.48B (72% of total)
Year-5 FCF
$175M
YearProjected FCFDiscounted PV
+1$129M$117M
+2$139M$115M
+3$150M$113M
+4$162M$111M
+5$175M$109M
Terminal$2.39B$1.48B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$431M
investment in PP&E
Stock-based comp (TTM)
$31M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$5.67B
everything owned
Total liabilities
$4.30B
everything owed
Stockholders' equity
$1.41B
shareholder claim
Net debt
$1.47B
LT debt minus cash

Recent performance · 5 quarters

Revenue
$987M
Net Income
$41M
Free Cash Flow
$78M

Drill down